These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 20021455)
101. The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility? Chun JN; Cho M; Park S; So I; Jeon JH Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188336. PubMed ID: 31870703 [TBL] [Abstract][Full Text] [Related]
102. Redirecting E2F1 to TA-p73 improves cancer therapy through apoptotic induction. El Dika M DNA Repair (Amst); 2020 Jun; 90():102858. PubMed ID: 32388489 [No Abstract] [Full Text] [Related]
103. To live or let die - complexity within the E2F1 pathway. Poppy Roworth A; Ghari F; La Thangue NB Mol Cell Oncol; 2015; 2(1):e970480. PubMed ID: 27308406 [TBL] [Abstract][Full Text] [Related]
104. E2F1-mediated apoptosis as a target of cancer therapy. Wu Z; Yu Q Curr Mol Pharmacol; 2009 Jun; 2(2):149-60. PubMed ID: 20021455 [TBL] [Abstract][Full Text] [Related]
105. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance. Engelmann D; Pützer BM Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184 [TBL] [Abstract][Full Text] [Related]
106. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy. Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018 [TBL] [Abstract][Full Text] [Related]